Novel study in Nairobi infants may accelerate path to HIV vaccine
Thursday, June 23, 2016 - 14:21
in Health & Medicine
The first and only study to look at isolate HIV-neutralizing antibodies from infants has found that novel antibodies that could protect against many variants of HIV can be produced relatively quickly after infection compared to adults. This suggests that various aspects of HIV-vaccine development, from design to administration, could be improved by mimicking infection and immune response in infants.